You've probably heard about intermittent fasting, and maybe alternate day fasting (ADF) has piqued your interest. It sounds straightforward enough: one day you eat, the next you don't – or at least, you drastically cut back. But what are the actual results when it comes to shedding pounds, and is it really a sustainable path for most people?
At its core, alternate day fasting involves a pattern of severe calorie restriction on "fast days" (often around 75% less than usual) followed by "feed days" where you eat without strict limits. It's a variation on the broader theme of intermittent fasting, which has gained significant traction as some find it more manageable than traditional daily calorie restriction.
When we look at the research, particularly in rodent models of obesity, ADF has shown some promising effects. Studies have indicated reductions in total cholesterol and triglyceride levels, a decrease in inflammatory gene expression, and improvements in liver steatosis. There's even a suggestion of a beneficial effect on factors related to cancer risk, like cell proliferation. That sounds pretty good, right?
However, when we shift our focus to human studies, the picture becomes a bit more nuanced. Sparse data from observational studies in humans have indeed pointed towards modest weight loss and some improvements in metabolic markers. Yet, the reality of extreme hunger on fasting days is a significant hurdle. For many, this intense feeling makes ADF difficult to stick with long-term, posing a challenge for its widespread adoption as a public health intervention.
Digging a little deeper, some research has directly compared ADF with daily calorie restriction (CR). Interestingly, while both approaches can lead to weight loss, one review noted that CR might actually result in superior decreases in body weight compared to IF/ADF regimens. However, the reduction in visceral fat mass, fasting insulin, and insulin resistance appeared comparable between the two. It's worth noting that neither intervention consistently produced clinically meaningful reductions in glucose concentrations.
Another variation, the 5:2 diet (where you restrict calories severely for two non-consecutive days a week and eat normally for the other five), has also been studied. Similar to ADF, studies comparing the 5:2 approach with daily calorie restriction have shown comparable reductions in body mass and fat mass. Modest improvements in fasting insulin and insulin resistance have also been observed in both groups.
So, what's the takeaway? Alternate day fasting, and intermittent fasting in general, shows promise as an alternative to daily calorie restriction for weight loss and potentially reducing the risk of type 2 diabetes, especially in overweight and obese populations. The metabolic benefits, particularly concerning visceral fat and insulin sensitivity, are encouraging. But it's not a magic bullet. The feasibility of maintaining such a restrictive pattern long-term, due to intense hunger, remains a significant consideration. More research is definitely needed before we can draw definitive conclusions, but it's certainly an interesting area to watch.
